Şükrü Gürbüz1, Mustafa Yıldız2, Murat Kara3, Kürşat Kargün4, Mehtap Gürger2, Metin Ateşçelik2, Ömer Doğan Alataş5. 1. Department of Emergency Medicine, İnönü University, Malatya, Turkey. 2. Department of Emergency Medicine, Fırat University, Elazığ, Turkey. 3. Department of Medical Genetics, Sıtkı Koçman University, Muğla, Turkey. 4. Department of Medical Genetics, Fırat University, Elazığ, Turkey. 5. Department of Emergency Medicine, Sıtkı Koçman University, Muğla, Turkey.
Abstract
BACKGROUND: The effect of increased oxidative stress on the development of chronic obstructive pulmonary disease (COPD) is well known. One of the antioxidative systems against oxidative stress in human body is paraoxonase (PON) enzyme that protects low density lipoproteins (LDL) against oxidation. This study aimed to explore the polymorphisms on PON1, Q192R, L55M genes of patients with COPD. METHODS: DNAs extraction was obtained from blood samples of 50 patients diagnosed with COPD and 50 patients as a control group who were presented to emergency clinic. Genotypes were obtained with polymerase chain reaction (PCR) and AIw I and Hsp92II restriction enzymes were used for Q192R and L55M polymorphisms, respectively. Analysis of data was done with the Chi-square test and Fisher's exact test. RESULTS: A statistically significant difference in Q192R polymorphism was found between the COPD patients and the control group (P=0.05). There was no statistically significant difference in L55M polymorphisms between the patient and control groups (P>0.05). Q192R polymorphism was significantly correlated with the PON1 gene and cigarette smoking; however other risk factors did not show any significant correlation with this polymorphism. Though L55M polymorphism was significantly correlated with family history and tuberculosis, there was no significant correlation with other risk factors. CONCLUSION: We believe that more studies are needed to study the correlation of L55M polymorphism with other factors.
BACKGROUND: The effect of increased oxidative stress on the development of chronic obstructive pulmonary disease (COPD) is well known. One of the antioxidative systems against oxidative stress in human body is paraoxonase (PON) enzyme that protects low density lipoproteins (LDL) against oxidation. This study aimed to explore the polymorphisms on PON1, Q192R, L55M genes of patients with COPD. METHODS: DNAs extraction was obtained from blood samples of 50 patients diagnosed with COPD and 50 patients as a control group who were presented to emergency clinic. Genotypes were obtained with polymerase chain reaction (PCR) and AIw I and Hsp92II restriction enzymes were used for Q192R and L55M polymorphisms, respectively. Analysis of data was done with the Chi-square test and Fisher's exact test. RESULTS: A statistically significant difference in Q192R polymorphism was found between the COPDpatients and the control group (P=0.05). There was no statistically significant difference in L55M polymorphisms between the patient and control groups (P>0.05). Q192R polymorphism was significantly correlated with the PON1 gene and cigarette smoking; however other risk factors did not show any significant correlation with this polymorphism. Though L55M polymorphism was significantly correlated with family history and tuberculosis, there was no significant correlation with other risk factors. CONCLUSION: We believe that more studies are needed to study the correlation of L55M polymorphism with other factors.
Authors: Ivana Stanojkovic; Jelena Kotur-Stevuljevic; Branislava Milenkovic; Slavica Spasic; Tatjana Vujic; Aleksandra Stefanovic; Aleksandra Llic; Jasmina Ivanisevic Journal: Respir Med Date: 2011-10 Impact factor: 3.415
Authors: Mario Bauer; Carolin Gräbsch; Uwe Schlink; Norman Klopp; Thomas Illig; Ursula Krämer; Andrea von Berg; Beate Schaaf; Michael Borte; Joachim Heinrich; Olf Herbarth; Irina Lehmann; Stefan Röder Journal: Metabolism Date: 2012-06-26 Impact factor: 8.694
Authors: Craig P Hersh; John E Hokanson; David A Lynch; George R Washko; Barry J Make; James D Crapo; Edwin K Silverman Journal: Chest Date: 2011-02-10 Impact factor: 9.410
Authors: Ana Maria B Menezes; Rogelio Perez-Padilla; José Roberto B Jardim; Adriana Muiño; Maria Victorina Lopez; Gonzalo Valdivia; Maria Montes de Oca; Carlos Talamo; Pedro C Hallal; Cesar G Victora Journal: Lancet Date: 2005-11-26 Impact factor: 79.321
Authors: Charlotte E Ruse; Maureen C Hill; Martin Tobin; Natalie Neale; Martin J Connolly; Stuart G Parker; Andrew J Wardlaw Journal: Respir Med Date: 2006-07-25 Impact factor: 3.415
Authors: Khalid Khalaf Alharbi; May Salem Alnbaheen; Fawiziah Khalaf Alharbi; Rana M Hasanato; Imran Ali Khan Journal: Ann Saudi Med Date: 2017 Nov-Dec Impact factor: 1.526